1Patel RS,Su S, Neeland U, et al. The chromosome 9p21 risk locus is associated with angiographic severity and progression of coronary artery disease. Eur Heart J, 2010,31: 3017-3023. 被引量：1
2Tantry US, Gurbel PA. Antiplatelet drug resistance and variability in response: the role of antiplatelet therapy monitoring. CUIT Pharm Des, 2013 ,19: 3795-3815. 被引量：1
4Huczek Z, Kochman J, Filipiak KJ, et al. Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention. J Am Coil Cardiol, 2005, 46: 284-290. 被引量：1
5Goncalves SC, Labinaz M, Le May M, et al. Usefulness of mean platelet volume as a biomarker for long-term outcomes after percutaneous coronary intervention. Am J Cardiol, 2011, 107 : 204-209. 被引量：1
6Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. J Am Coil Cardiol, 2012,60: 1581- 1598. 被引量：1
72012 Writing Committee Members, Ineid H, Anderson JL, et al. 2012 ACCFI AHA focused update of the guideline for the management of patients with unstable anginaiNon-ST -elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation! American Heart Association Task Force on practice guidelines. Circulation, 2012,126: 875-910. 被引量：1
8Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, et al. Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting. Thromb Res, 2005,115: 101-108. 被引量：1
9Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation, 2007,115 :2344-2351. 被引量：1
10Shab B, Sha D, Xie D, et al. The relationship between diabetes, metabolic syndrome, and platelet activity as measured by mean platelet volume: the National Health And Nutrition Examination Survey, 1999-2004. Diabetes Care, 2012,35: 1074-1078. 被引量：1
